• Je něco špatně v tomto záznamu ?

The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers

E. Compérat, MB. Amin, JI. Epstein, DE. Hansel, G. Paner, H. Al-Ahmadie, L. True, D. Bayder, T. Bivalacqua, F. Brimo, L. Cheng, J. Cheville, G. Dalbagni, S. Falzarano, J. Gordetsky, C. Guo, S. Gupta, O. Hes, G. Iyer, S. Kaushal, L. Kunju, C....

. 2021 ; 28 (4) : 196-208. [pub] 2021Jul01

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, směrnice pro lékařskou praxi, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21025411

The Genitourinary Pathology Society (GUPS) undertook a critical review of the recent advances in bladder cancer focusing on important topics of high interest for the practicing surgical pathologist and urologist. This review represents the second of 2 manuscripts ensuing from this effort. Herein, we address the effective reporting of bladder cancer, focusing particularly on newly published data since the last 2016 World Health Organization (WHO) classification. In addition, this review focuses on the importance of reporting bladder cancer with divergent differentiation and variant (subtypes of urothelial carcinoma) histologies and the potential impact on patient care. We provide new recommendations for reporting pT1 staging in diagnostic pathology. Furthermore, we explore molecular evolution and classification, emphasizing aspects that impact the understanding of important concepts relevant to reporting and management of patients.

Department of Histopathology and Molecular Diagnostics University Hospital Careggi Florence Italy

Department of Pathology All India Institute of Medical Sciences New Delhi Delhi India

Department of Pathology and Laboratory Medicine Cumming School of Medicine University of Calgary Calgary AB Canada

Department of Pathology and Laboratory Medicine Indiana University School of Medicine Indianapolis IN

Department of Pathology and Laboratory Medicine Oregon Health Science University OR

Department of Pathology and Laboratory Medicine University of South Florida Gainesville FL

Department of Pathology and Laboratory Medicine University of Tennessee Health Science Memphis

Department of Pathology Charles University Prague Faculty of Medicine and University Hospital in Plzen Plzen Czech Republic

Department of Pathology Hôpital Tenon Sorbonne University

Department of Pathology Koc Univiversity School of Medicine Istanbul Turkey

Department of Pathology Mayo Clinic Rochester MN

Department of Pathology MD Anderson Cancer Center Houston

Department of Pathology Medical University Vienna Vienna General Hospital

Department of Pathology Montreal QC

Department of Pathology Taipei Veterans General Hospital Tapeh Taiwan

Department of Pathology The University of Alabama at Birmingham Birmingham AL

Department of Pathology Tufts Medical Center Boston MA

Department of Pathology University of Chicago Chicago IL

Department of Pathology University of Erlangen Nuremberg Erlangen Germany

Department of Pathology University of Michigan Medical School Ann Arbor MI

Department of Pathology University of Washington School of Medicine Seattle Washington DC

Department of Pathology West German Cancer Center University Hospital Essen University of Duisburg Essen Duisburg

Department of Urology APHP Sorbonne University Paris France

Department of Urology Comprehensive Cancer Center Medical University Vienna Vienna Austria

Department of Urology University of Southern California Keck School of Medicine Los Angeles CA

Departments of Pathology

Departments of Pathology Microbiology and Immunology

Medical Oncology

Oncology Memorial Sloan Kettering Cancer Center New York NY

Oncology The Johns Hopkins Medical Institutions Baltimore MD

Robert J Tomsich Pathology and Laboratory Medicine Institute Cleveland Clinic Cleveland OH

Urology

Urology Emory University School of Medicine Atlanta GA

Urology Simmons Comprehensive Cancer Center University of Texas Southwestern Medical Center Dallas TX

Urology Vanderbilt University Medical Center Nashville TN

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21025411
003      
CZ-PrNML
005      
20211026133837.0
007      
ta
008      
211013s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/PAP.0000000000000309 $2 doi
035    __
$a (PubMed)34128484
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Compérat, Eva $u Department of Pathology, Medical University Vienna, Vienna General Hospital $u Department of Pathology, Hôpital Tenon, Sorbonne University
245    14
$a The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers / $c E. Compérat, MB. Amin, JI. Epstein, DE. Hansel, G. Paner, H. Al-Ahmadie, L. True, D. Bayder, T. Bivalacqua, F. Brimo, L. Cheng, J. Cheville, G. Dalbagni, S. Falzarano, J. Gordetsky, C. Guo, S. Gupta, O. Hes, G. Iyer, S. Kaushal, L. Kunju, C. Magi-Galluzzi, A. Matoso, J. McKenney, GJ. Netto, AO. Osunkoya, CC. Pan, K. Pivovarcikova, MR. Raspollini, H. Reis, J. Rosenberg, M. Roupret, RB. Shah, SF. Shariat, K. Trpkov, V. Weyerer, M. Zhou, V. Reuter
520    9_
$a The Genitourinary Pathology Society (GUPS) undertook a critical review of the recent advances in bladder cancer focusing on important topics of high interest for the practicing surgical pathologist and urologist. This review represents the second of 2 manuscripts ensuing from this effort. Herein, we address the effective reporting of bladder cancer, focusing particularly on newly published data since the last 2016 World Health Organization (WHO) classification. In addition, this review focuses on the importance of reporting bladder cancer with divergent differentiation and variant (subtypes of urothelial carcinoma) histologies and the potential impact on patient care. We provide new recommendations for reporting pT1 staging in diagnostic pathology. Furthermore, we explore molecular evolution and classification, emphasizing aspects that impact the understanding of important concepts relevant to reporting and management of patients.
650    _2
$a nádorové biomarkery $x metabolismus $7 D014408
650    _2
$a karcinom z přechodných buněk $x farmakoterapie $x metabolismus $x patologie $7 D002295
650    _2
$a lidé $7 D006801
650    12
$a imunoterapie $7 D007167
650    _2
$a staging nádorů $7 D009367
650    _2
$a urologické nádory $x farmakoterapie $x metabolismus $x patologie $7 D014571
655    _2
$a časopisecké články $7 D016428
655    _2
$a směrnice pro lékařskou praxi $7 D017065
655    _2
$a přehledy $7 D016454
700    1_
$a Amin, Mahul B $u Department of Pathology and Laboratory Medicine, University of Tennessee Health Science, Memphis $u Department of Urology, University of Southern California Keck School of Medicine, Los Angeles, CA
700    1_
$a Epstein, Jonathan I $u Departments of Pathology $u Urology $u Oncology, The Johns Hopkins Medical Institutions, Baltimore, MD
700    1_
$a Hansel, Donna E $u Department of Pathology & Laboratory Medicine, Oregon Health Science University, OR
700    1_
$a Paner, Gladell $u Department of Pathology, University of Chicago, Chicago, IL
700    1_
$a Al-Ahmadie, Hikmat $u Departments of Pathology
700    1_
$a True, Larry $u Department of Pathology, University of Washington School of Medicine, Seattle, Washington, DC
700    1_
$a Bayder, Dilek $u Department of Pathology, Koc Univiversity School of Medicine, Istanbul, Turkey
700    1_
$a Bivalacqua, Trinity $u Oncology, The Johns Hopkins Medical Institutions, Baltimore, MD
700    1_
$a Brimo, Fadi $u Department of Pathology, Montreal, QC
700    1_
$a Cheng, Liang $u Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN
700    1_
$a Cheville, John $u Department of Pathology, Mayo Clinic, Rochester, MN
700    1_
$a Dalbagni, Guido $u Urology
700    1_
$a Falzarano, Sara $u Department of Pathology and Laboratory Medicine, University of South Florida, Gainesville, FL
700    1_
$a Gordetsky, Jennifer $u Departments of Pathology, Microbiology, and Immunology $u Urology, Vanderbilt University Medical Center, Nashville, TN
700    1_
$a Guo, Charles $u Department of Pathology, MD Anderson Cancer Center, Houston
700    1_
$a Gupta, Sounak $u Department of Pathology, Mayo Clinic, Rochester, MN
700    1_
$a Hes, Ondrej $u Department of Pathology, Charles University in Prague, Faculty of Medicine and University Hospital in Plzen, Plzen, Czech Republic
700    1_
$a Iyer, Gopa $u Medical Oncology
700    1_
$a Kaushal, Seema $u Department of Pathology, All India Institute of Medical Sciences, New Delhi, Delhi, India
700    1_
$a Kunju, Lakshmi $u Department of Pathology, University of Michigan Medical School, Ann Arbor, MI
700    1_
$a Magi-Galluzzi, Cristina $u Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL
700    1_
$a Matoso, Andres $u Departments of Pathology $u Urology
700    1_
$a McKenney, Jesse $u Robert J Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH
700    1_
$a Netto, George J $u Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL
700    1_
$a Osunkoya, Adeboye O $u Departments of Pathology $u Urology, Emory University School of Medicine, Atlanta, GA
700    1_
$a Pan, Chin Chen $u Department of Pathology, Taipei Veterans General Hospital, Tapeh, Taiwan
700    1_
$a Pivovarcikova, Kristina $u Department of Pathology, Charles University in Prague, Faculty of Medicine and University Hospital in Plzen, Plzen, Czech Republic
700    1_
$a Raspollini, Maria R $u Department of Histopathology and Molecular Diagnostics, University Hospital Careggi, Florence, Italy
700    1_
$a Reis, Henning $u Department of Pathology, West German Cancer Center/University Hospital Essen, University of Duisburg-Essen, Duisburg
700    1_
$a Rosenberg, Jonathan $u Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
700    1_
$a Roupret, Morgan $u Department of Urology, APHP Sorbonne University, Paris, France
700    1_
$a Shah, Rajal B $u Departments of Pathology $u Urology, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX
700    1_
$a Shariat, Shahrokh F $u Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna, Austria
700    1_
$a Trpkov, Kiril $u Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
700    1_
$a Weyerer, Veronika $u Department of Pathology, University of Erlangen-Nuremberg, Erlangen, Germany
700    1_
$a Zhou, Ming $u Department of Pathology, Tufts Medical Center, Boston, MA
700    1_
$a Reuter, Victor $u Departments of Pathology
773    0_
$w MED00000158 $t Advances in anatomic pathology $x 1533-4031 $g Roč. 28, č. 4 (2021), s. 196-208
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34128484 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133843 $b ABA008
999    __
$a ok $b bmc $g 1714448 $s 1145918
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 28 $c 4 $d 196-208 $e 2021Jul01 $i 1533-4031 $m Advances in anatomic pathology $n Adv Anat Pathol $x MED00000158
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...